SOLUTIONS THAT MEET YOUR DEMANDS FOR FORENSIC TOXICOLOGY
Guides | 2010 | Agilent TechnologiesInstrumentation
Monitoring oxycodone, cocaine and their metabolites in biological fluids is critical for forensic toxicology and clinical pharmacology. Liquid chromatography–mass spectrometry (LC/MS) approaches offer sensitive, derivatization‐free analysis, simplifying workflows and improving throughput over traditional GC/MS methods.
Key analytes include:
Biological specimens (typically 1 mL) are fortified with deuterated internal standards, buffered, and subjected to solid‐phase extraction (mixed‐mode SPE columns). Eluates are evaporated, reconstituted in mobile phase, and injected for LC/MS, omitting derivatization.
Rapid separations use 2.1×50–150 mm RRHT or StableBond SB‐C18 columns (1.8–3 μm particles) at elevated temperatures (30–60 °C). Mobile phases: aqueous ammonium formate or formic acid buffers and organic modifier (acetonitrile or methanol) under isocratic or short gradients (run times 5–9 min).
Five instrument platforms were compared:
• Linearity: R2 > 0.99 over three or more concentration decades
• Precision: CV < 10% at low‐ng/mL levels
• Limits of quantitation: down to 0.02–0.5 ng/mL depending on analyte and instrument
• Fast cycle times: 5–9 min including re‐equilibration in some methods
• Case samples: real postmortem and DUID blood/urine analyses demonstrated accurate quantitation and confirmation across platforms
LC/MS allows comprehensive analysis of opioids, cocaine and metabolites, and benzodiazepines without derivatization. QQQ provides best quantitative sensitivity and confirmation; SQ offers simple, routine quantification; IT excels in qualitative MSn screening; TOF/QTOF adds accurate‐mass identification and screening capabilities. Choice of MS depends on required sensitivity, confirmation, and screening breadth.
[1] Broussard et al., Clin. Chem. 1997;43:1029–1032
[2] Slawson et al., J. Anal. Toxicol. 1999;23:468–473
[3] Feyerherm et al., Agilent App. Note 988-4805EN
GC, GC/MSD, GC/MS/MS, HeadSpace, Sample Preparation, GC/SQ, GC/QQQ, Consumables, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns, LC/QQQ, LC/SQ, Capillary electrophoresis, ICP/MS, ICP-OES
IndustriesForensics
ManufacturerAgilent Technologies
Summary
Significance
Monitoring oxycodone, cocaine and their metabolites in biological fluids is critical for forensic toxicology and clinical pharmacology. Liquid chromatography–mass spectrometry (LC/MS) approaches offer sensitive, derivatization‐free analysis, simplifying workflows and improving throughput over traditional GC/MS methods.
Analytes and Matrices
Key analytes include:
- Oxycodone and metabolites: noroxycodone, oxymorphone, noroxymorphone
- Cocaine and metabolites: benzoylecgonine (BE), cocaethylene (CE), norcocaine
- Benzodiazepines: alprazolam, diazepam, nordiazepam, others
- Methadone, morphine, hydromorphone, codeine, hydrocodone, 6‐acetylmorphine
Sample Preparation
Biological specimens (typically 1 mL) are fortified with deuterated internal standards, buffered, and subjected to solid‐phase extraction (mixed‐mode SPE columns). Eluates are evaporated, reconstituted in mobile phase, and injected for LC/MS, omitting derivatization.
Chromatography
Rapid separations use 2.1×50–150 mm RRHT or StableBond SB‐C18 columns (1.8–3 μm particles) at elevated temperatures (30–60 °C). Mobile phases: aqueous ammonium formate or formic acid buffers and organic modifier (acetonitrile or methanol) under isocratic or short gradients (run times 5–9 min).
Mass Spectrometry
Five instrument platforms were compared:
- Single quadrupole (SQ) in selected ion monitoring (SIM) mode—quantitative, LOQs 5 ng/mL (cocaine, BE), 10 ng/mL (CE)
- Triple quadrupole (QQQ) in multiple reaction monitoring (MRM)—highest quantitative sensitivity (LOQs 0.5–2 ng/mL), confirmation by qualifier ion ratios
- Ion trap (IT) in full‐scan MS/MS and MS3 (AutoMSn)—excellent qualitative screening, library matching of fragmentation patterns
- Time‐of‐flight (TOF)—accurate‐mass full scan MS quantification (±2 ppm), and screening by exact mass EICs (±10 ppm)
- Quadrupole TOF (QTOF)—accurate‐mass MS and MS/MS identification, quantitative capabilities in MS mode
Key Performance
• Linearity: R2 > 0.99 over three or more concentration decades
• Precision: CV < 10% at low‐ng/mL levels
• Limits of quantitation: down to 0.02–0.5 ng/mL depending on analyte and instrument
• Fast cycle times: 5–9 min including re‐equilibration in some methods
• Case samples: real postmortem and DUID blood/urine analyses demonstrated accurate quantitation and confirmation across platforms
Conclusions
LC/MS allows comprehensive analysis of opioids, cocaine and metabolites, and benzodiazepines without derivatization. QQQ provides best quantitative sensitivity and confirmation; SQ offers simple, routine quantification; IT excels in qualitative MSn screening; TOF/QTOF adds accurate‐mass identification and screening capabilities. Choice of MS depends on required sensitivity, confirmation, and screening breadth.
References
[1] Broussard et al., Clin. Chem. 1997;43:1029–1032
[2] Slawson et al., J. Anal. Toxicol. 1999;23:468–473
[3] Feyerherm et al., Agilent App. Note 988-4805EN
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Shimadzu Journal Vol. 10 - Forensics / Toxicology
2023|Shimadzu|Others
Vol ISSUE2 SJ23_0102 ISSN 2188-0484 Forensics / Toxicology Note from the Director Masami Tomita General Manager, Analytical & Measurement Instruments Division I am Masami Tomita, the new General Manager of the Analytical and Measuring Instruments Division. I have replaced Yoshiaki…
Key words
toxicology, toxicologyhair, hairforensics, forensicsshimadzu, shimadzuinfrared, infraredraman, ramanluiz, luizyou, youpermed, permedmass, massairsight, airsightresearch, researchdrugs, drugsmicroscope, microscopeinsight
Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation
2010|Agilent Technologies|Guides
Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation Application Compendium Introduction The analysis of impurities in drugsubstances, from initial screening to the use of validated methods in routine quality control and quality assurance, is becoming an increasingly challenging…
Key words
mass, massagilent, agilentformula, formulatime, timemau, maumin, minwere, wereamoxicillin, amoxicillinxylene, xylenemda, mdappm, ppmmethod, methodimpurities, impuritiesfrom, fromanalysis
Shimadzu journal Vol. 02 - Forensics / Toxicology
2014|Shimadzu|Others
(w215 h280) 2 SJ14_0024 ISSN 2188-0484 Shimadzu 02 Forensics / Toxicology and more… Shimadzu welcomes your idea and input! Questionnaire www.shimadzu.com/an/ For Research Use Only. Not for use in diagnostic procedures. The content of this publication shall not be reproduced,…
Key words
cannabis, cannabisforensics, forensicsmarijuana, marijuanashimadzu, shimadzuskyline, skylinetopics, topicsremedies, remediestoxicological, toxicologicalurine, urineherbal, herbaldrugs, drugscollaboration, collaborationproteomics, proteomicsforensic, forensicfrom
Shimadzu Analysis Guidebook Pharmaceutical Analyses
2013|Shimadzu|Guides
C219-E001C Shimadzu Analysis Guidebook Pharmaceutical Analyses Index 1. General Pharmaceuticals 3. Quasi-Drugs 1. 1 Analysis of Cold Medicine - GC ··························································1 3. 1 Analysis of Hair Tonic - LC ······························································ 35 1. 2 High Speed Analysis of Cold Medicine (1)…
Key words
plq, plqflowrate, flowrateexplanation, explanationrpsrxqg, rpsrxqganalysis, analysisanalytical, analyticalconditions, conditionscolumn, columndetection, detectionmeasurement, measurementusing, usingtoc, tocdrugs, drugsointment, ointmentconducted